Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.
Sanne Y Smith-ApeldoornJolien K E VeraartJeanine KamphuisAntoinette D I van AsseltDaan J TouwMarije Aan Het RotRobert A SchoeversPublished in: BMC psychiatry (2019)
Dutch Trial Register, NTR6161. Registered 21 October 2016.